JP2010227106A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010227106A5 JP2010227106A5 JP2010108289A JP2010108289A JP2010227106A5 JP 2010227106 A5 JP2010227106 A5 JP 2010227106A5 JP 2010108289 A JP2010108289 A JP 2010108289A JP 2010108289 A JP2010108289 A JP 2010108289A JP 2010227106 A5 JP2010227106 A5 JP 2010227106A5
- Authority
- JP
- Japan
- Prior art keywords
- immune
- disease
- test
- biological sample
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 24
- 239000012472 biological sample Substances 0.000 claims 12
- 241000124008 Mammalia Species 0.000 claims 10
- 210000004027 cell Anatomy 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 201000010099 disease Diseases 0.000 claims 9
- 230000014509 gene expression Effects 0.000 claims 8
- 230000002757 inflammatory effect Effects 0.000 claims 7
- 229920001184 polypeptide Polymers 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims 7
- 230000028993 immune response Effects 0.000 claims 6
- 230000001404 mediated effect Effects 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 4
- 210000001744 T-lymphocyte Anatomy 0.000 claims 4
- 239000013068 control sample Substances 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 208000026278 immune system disease Diseases 0.000 claims 3
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 2
- 206010036105 Polyneuropathy Diseases 0.000 claims 2
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 208000005252 hepatitis A Diseases 0.000 claims 2
- 201000010284 hepatitis E Diseases 0.000 claims 2
- 238000009396 hybridization Methods 0.000 claims 2
- 230000021633 leukocyte mediated immunity Effects 0.000 claims 2
- 230000007824 polyneuropathy Effects 0.000 claims 2
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000032467 Aplastic anaemia Diseases 0.000 claims 1
- 241000972773 Aulopiformes Species 0.000 claims 1
- 206010003827 Autoimmune hepatitis Diseases 0.000 claims 1
- 206010050245 Autoimmune thrombocytopenia Diseases 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 1
- 206010008609 Cholangitis sclerosing Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000016192 Demyelinating disease Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
- 206010015150 Erythema Diseases 0.000 claims 1
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 1
- 206010016946 Food allergy Diseases 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 108010068370 Glutens Proteins 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 208000003807 Graves Disease Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 208000001204 Hashimoto Disease Diseases 0.000 claims 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims 1
- 208000005176 Hepatitis C Diseases 0.000 claims 1
- 208000005331 Hepatitis D Diseases 0.000 claims 1
- 208000037319 Hepatitis infectious Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 201000002481 Myositis Diseases 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- 208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 claims 1
- 102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 208000006045 Spondylarthropathies Diseases 0.000 claims 1
- 201000009594 Systemic Scleroderma Diseases 0.000 claims 1
- 208000004732 Systemic Vasculitis Diseases 0.000 claims 1
- 206010042953 Systemic sclerosis Diseases 0.000 claims 1
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 208000027207 Whipple disease Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 208000010927 atrophic thyroiditis Diseases 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 208000019748 bullous skin disease Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 201000001981 dermatomyositis Diseases 0.000 claims 1
- 229960000633 dextran sulfate Drugs 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000010643 digestive system disease Diseases 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 201000009580 eosinophilic pneumonia Diseases 0.000 claims 1
- 231100000321 erythema Toxicity 0.000 claims 1
- 235000021312 gluten Nutrition 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 201000007192 granulomatous hepatitis Diseases 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 208000013643 idiopathic inflammatory myopathy Diseases 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 201000006334 interstitial nephritis Diseases 0.000 claims 1
- 230000000366 juvenile effect Effects 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 230000002018 overexpression Effects 0.000 claims 1
- 201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 claims 1
- 208000005987 polymyositis Diseases 0.000 claims 1
- 208000028172 protozoa infectious disease Diseases 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 201000009732 pulmonary eosinophilia Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 235000019515 salmon Nutrition 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 208000010157 sclerosing cholangitis Diseases 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 229940048086 sodium pyrophosphate Drugs 0.000 claims 1
- 201000005671 spondyloarthropathy Diseases 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims 1
- 206010043554 thrombocytopenia Diseases 0.000 claims 1
- 206010043778 thyroiditis Diseases 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41017402P | 2002-09-11 | 2002-09-11 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004536436A Division JP2006512903A (ja) | 2002-09-11 | 2003-09-10 | 免疫関連疾患の治療のための新規組成物と方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012210684A Division JP2013051961A (ja) | 2002-09-11 | 2012-09-25 | 免疫関連疾患の治療のための新規組成物と方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010227106A JP2010227106A (ja) | 2010-10-14 |
| JP2010227106A5 true JP2010227106A5 (cg-RX-API-DMAC7.html) | 2011-07-28 |
Family
ID=31994084
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004536436A Pending JP2006512903A (ja) | 2002-09-11 | 2003-09-10 | 免疫関連疾患の治療のための新規組成物と方法 |
| JP2010108289A Pending JP2010227106A (ja) | 2002-09-11 | 2010-05-10 | 免疫関連疾患の治療のための新規組成物と方法 |
| JP2012210684A Withdrawn JP2013051961A (ja) | 2002-09-11 | 2012-09-25 | 免疫関連疾患の治療のための新規組成物と方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004536436A Pending JP2006512903A (ja) | 2002-09-11 | 2003-09-10 | 免疫関連疾患の治療のための新規組成物と方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012210684A Withdrawn JP2013051961A (ja) | 2002-09-11 | 2012-09-25 | 免疫関連疾患の治療のための新規組成物と方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20060281146A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2116616A3 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2006512903A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2003267096B9 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2497661A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004024076A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006230099B2 (en) | 2005-03-25 | 2012-04-19 | Gitr, Inc. | GITR binding molecules and uses therefor |
| EP2175884B8 (en) | 2007-07-12 | 2017-02-22 | GITR, Inc. | Combination therapies employing gitr binding molecules |
| JP2010539243A (ja) * | 2007-09-18 | 2010-12-16 | ラ ホヤ インスティテュート フォア アラージー アンド イムノロジー | 喘息、肺及び気道の炎症、呼吸器、間質性、肺性および線維性疾患の処置のためのｌｉｇｈｔ阻害剤 |
| JP2012507299A (ja) | 2008-10-31 | 2012-03-29 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Ｌｉｇｈｔ標的分子およびその使用 |
| MY181896A (en) | 2014-06-06 | 2021-01-12 | Bristol Myers Squibb Co | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof |
| ES2810856T3 (es) | 2015-06-03 | 2021-03-09 | Bristol Myers Squibb Co | Anticuerpos ANTI-GITR para diagnóstico de cáncer |
| JP6983776B2 (ja) | 2015-11-19 | 2021-12-17 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | グルココルチコイド誘発腫瘍壊死因子受容体（ｇｉｔｒ）に対する抗体およびその使用 |
| KR20200006115A (ko) | 2017-05-16 | 2020-01-17 | 브리스톨-마이어스 스큅 컴퍼니 | 항-gitr 효능제 항체에 의한 암의 치료 |
| WO2019000144A1 (zh) * | 2017-06-26 | 2019-01-03 | 深圳市博奥康生物科技有限公司 | 一种表达aitr基因的cho细胞及其应用 |
| US12012441B2 (en) | 2020-10-26 | 2024-06-18 | Neptune Biosciences Llc | Engineered human IL-21 cytokines and methods for using the same |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
| US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
| IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| ATE186219T1 (de) | 1993-03-24 | 1999-11-15 | Berlex Biosciences | Kombination von antihormonale und bindende moleküle zur krebsbehandlung |
| WO2000037640A2 (en) * | 1998-12-22 | 2000-06-29 | Genentech, Inc. | Compositions and methods for the treatment of tumor |
| AU2582897A (en) | 1996-03-15 | 1997-10-01 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
| US5861308A (en) * | 1996-08-21 | 1999-01-19 | Ludwig Institute For Cancer Research | Isolated nucleic acids associated with T cell activation and uses thereof |
| US5871965A (en) * | 1996-10-25 | 1999-02-16 | Incyte Pharmaceuticals, Inc. | Guanylate binding proteins |
| WO2002000690A2 (en) * | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| US6069229A (en) * | 1997-03-07 | 2000-05-30 | Schering Corporation | Mammalian proteinases; oxidoreductases; related reagents |
| US6482923B1 (en) * | 1997-09-17 | 2002-11-19 | Human Genome Sciences, Inc. | Interleukin 17-like receptor protein |
| AU2212299A (en) * | 1998-01-05 | 1999-07-26 | Genentech Inc. | Compositions and methods for the treatment of tumor |
| NZ531664A (en) * | 1998-09-01 | 2005-07-29 | Genentech Inc | Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family |
| CA2346496A1 (en) * | 1998-10-07 | 2000-04-13 | Millennium Pharmaceuticals, Inc. | Novel th2-specific molecules and uses thereof |
| ES2287020T3 (es) * | 1999-06-02 | 2007-12-16 | Genentech, Inc. | Procedimiento y composiciones para inhibir el crecimiento de celulas neoplasicas. |
| AU2883700A (en) * | 1999-06-23 | 2001-01-09 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CA2384055A1 (en) * | 1999-08-31 | 2001-03-08 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| CA2490909A1 (en) * | 1999-12-01 | 2001-06-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| ES2380812T3 (es) * | 1999-12-23 | 2012-05-18 | Genentech, Inc. | Polipéptidos homólogos a IL-17 y usos terapéuticos de los mismos |
| AU2404001A (en) * | 2000-01-06 | 2001-07-16 | Protegene Inc. | Human proteins having hydrophobic domains and dnas encoding these proteins |
| US7094886B2 (en) * | 2000-02-04 | 2006-08-22 | Board Of Trustees Of The University Of Arkansas | Evi27 gene sequences and protein encoded thereby |
| TWI322154B (en) * | 2000-03-16 | 2010-03-21 | Amgen Inc | Il-17 receptor like molecules and uses thereof |
| AU2001274920A1 (en) * | 2000-05-24 | 2001-12-03 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
| CA2416538A1 (en) * | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| ATE478148T1 (de) * | 2000-07-27 | 2010-09-15 | Wyeth Llc | Verwendung von il-10 rezeptor beta antagonistische antikörper zur hemmung einer il- tif/il-21 induktion von akutphasen-proteine |
| US20030045688A1 (en) * | 2000-08-25 | 2003-03-06 | Chu Charles Chiyuan | Human interleukin-four induced protein |
| WO2002022660A2 (en) * | 2000-09-11 | 2002-03-21 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| DE10055285A1 (de) * | 2000-11-08 | 2002-06-06 | Deutsches Krebsforsch | Neue Marker für die Diagnose und Therapie von Tumoren |
| EP2332956A1 (en) * | 2002-07-08 | 2011-06-15 | Genentech, Inc. | Antibody binding to PRO71238 |
| JP2004121218A (ja) * | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
-
2003
- 2003-09-10 JP JP2004536436A patent/JP2006512903A/ja active Pending
- 2003-09-10 US US10/527,469 patent/US20060281146A1/en not_active Abandoned
- 2003-09-10 EP EP09007584A patent/EP2116616A3/en not_active Withdrawn
- 2003-09-10 AU AU2003267096A patent/AU2003267096B9/en not_active Ceased
- 2003-09-10 WO PCT/US2003/028361 patent/WO2004024076A2/en not_active Ceased
- 2003-09-10 EP EP03749572A patent/EP1562587A4/en not_active Withdrawn
- 2003-09-10 CA CA002497661A patent/CA2497661A1/en not_active Abandoned
-
2008
- 2008-10-29 US US12/290,404 patent/US20090098120A1/en not_active Abandoned
-
2010
- 2010-04-12 AU AU2010201437A patent/AU2010201437B9/en not_active Ceased
- 2010-05-10 JP JP2010108289A patent/JP2010227106A/ja active Pending
-
2011
- 2011-02-10 US US13/025,008 patent/US20110243930A1/en not_active Abandoned
-
2012
- 2012-09-25 JP JP2012210684A patent/JP2013051961A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012254093A5 (cg-RX-API-DMAC7.html) | ||
| JP2010227106A5 (cg-RX-API-DMAC7.html) | ||
| JP2010187677A5 (cg-RX-API-DMAC7.html) | ||
| JP2010162017A5 (cg-RX-API-DMAC7.html) | ||
| CN102181581B (zh) | 犬瘟热病毒、肠炎细小病毒和阿留申病毒的三重pcr试剂盒 | |
| JP2011050389A5 (cg-RX-API-DMAC7.html) | ||
| JP2010220614A5 (cg-RX-API-DMAC7.html) | ||
| JP2006516094A5 (cg-RX-API-DMAC7.html) | ||
| RU2009142808A (ru) | Новые полностью человеческие моноклональные антитела против vap-1 | |
| JP2009136300A5 (cg-RX-API-DMAC7.html) | ||
| CN103866046A (zh) | 人疱疹病毒ebv和vzv检测试剂盒 | |
| Vanspauwen et al. | Infections with mimivirus in patients with chronic obstructive pulmonary disease | |
| Gao et al. | Construction and identification of a cDNA library for use in the yeast two-hybrid system from duck embryonic fibroblast cells post-infected with duck enteritis virus | |
| Cui et al. | Identification and genetic characterization of a novel circular single-stranded DNA virus in a human upper respiratory tract sample | |
| Kang et al. | Prevalence of severe fever with thrombocytopenia syndrome virus in black goats (Capra hircus coreanae) in the Republic of Korea | |
| Mäntynen et al. | New enveloped dsRNA phage from freshwater habitat | |
| CN101921832A (zh) | 用于检测致病疫霉的引物、试剂盒及检测方法 | |
| CN106148298A (zh) | 水稻抗病相关基因OsDR11及其在水稻抗病中的应用 | |
| Kozlowska-Makulska et al. | Phylogenetic relationships and the occurrence of interspecific recombination between beet chlorosis virus (BChV) and Beet mild yellowing virus (BMYV) | |
| CN102899425B (zh) | 一种鸽疱疹病毒的检测试剂盒 | |
| CN111172326B (zh) | 一种体外检测rhTSG-6抗病毒活性的方法及rhTSG-6在抗病毒药物中的应用 | |
| CN114163521B (zh) | 一种鉴别猪瘟病毒2.1亚型强毒株及其抗体的单克隆抗体 | |
| CN104611343A (zh) | 分离的鲤抗病毒天然免疫蛋白trim32及抗病毒活性 | |
| CN103805580B (zh) | 基于s-层蛋白体外自组装的多功能生物纳米材料 | |
| JP2006254750A (ja) | コイヘルペスウイルス（ｋｈｖ）の検出法 |